Skip to main content
Clinical Trials/JPRN-UMIN000002997
JPRN-UMIN000002997
Completed
未知

ife-style related desease and cardiovascular disease study - The Osaka University Visceral Fat Study (O-VFStudy)

Osaka University0 sites100 target enrollmentJuly 8, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
ife-style related disease
Sponsor
Osaka University
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 8, 2010
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The effect of different cardiovascular risk presentation formats on individuals? intentions, understanding and emotional affect.
ISRCTN91319318Cardiff University (UK)800
Active, not recruiting
Phase 1
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-003946-34-CZVIVUS, Inc.16,000
Active, not recruiting
Phase 1
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 14.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-003946-34-SKVIVUS, Inc.16,000
Active, not recruiting
Not Applicable
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.0Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-003946-34-GBVIVUS, Inc.16,000
Not yet recruiting
Not Applicable
Investigating the Effect of Plant Based Diets on Cardiovascular Disease Risk
ACTRN12621000743864niversity of Newcastle240